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Diastolic dysfunction and left ventricular outflow trait (LVOT) obstruction are
major determinants of symptoms and disability in hypertrophic cardiomyopa-
thy (HCM) patients. Disopyramide (Dis), Ranolazine (Ran) and the novel com-
pound GS-967 are late Na-current blockers with progressively increasing
selectivity for late vs. peak Na current. Dis is employed in HCM patients as
an agent to relieve obstruction, but the cellular basis of its negative inotropic
effect remains unknown. We previously showed that Ran ameliorates the dia-
stolic properties of trabeculae from HCM patients, with no effects on baseline
systolic force (Coppini et al, Circulation 2013). Here, we aim to study the ef-
fects of late Na-current blockers on diastolic function and contractility of
HCM myocardium. Patch-clamp studies and intracellular-Ca2þ recordings
were performed in isolated myocytes from myectomy samples of obstructive
HCM patients; intact trabeculae were used for mechanical measurements.
Dis (5mM) reduced twitch tension in a dose dependent manner (EC50:
5.2951.55mM) and accelerated contraction kinetics in HCM trabeculae. Ran
(10mM), despite no significant effect on the amplitude of baseline contraction,
significantly reduced isometric twitch tension when applied on top of isoproter-
enol 10-6M (IsoþRan). Contraction kinetics in IsoþRan were still significantly
faster than baseline. The late Na-current blocker GS-967 (1mM) did not reduce
baseline twitch force but accelerated contraction kinetics, highlighting qualita-
tively similar effects compared to Ran, albeit at 1/10 concentration. Intracel-
lular Ca2þ measurements and patch clamp studies performed in HCM
cardiomyocytes suggest that most of these mechanical effects are mediated
by inhibition of the up-regulated INaL via normalization of NCX function
and intracellular [Ca2þ]. From the clinical perspective: (i)all the three drugs
may reduce diastolic dysfunction by speeding up contraction kinetics; (ii)Ran
and GS-967 may reduce septal contractility only at peak exercise, representing
a safer option to treat obstruction compared to Dis.
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In cardiacmuscle fromHCMpatients primary changes inmyofilament function,
related to the presence of disease-causing mutations in sarcomeric proteins, are
always associated with secondary abnormalities due to adverse remodeling of
cardiomyocyte EC-coupling(Coppini et al,Circulation 2013). The latter are
likely major contributors of the mechanical dysfunction and arrhythmogeneity
of HCM human hearts. Here we characterize the changes in sarcomere function
and EC-coupling that occur in two HCM mouse models carrying different mu-
tations in cTnT (R92Q andE163R). Echocardiography showedLVhypertrophy,
enhanced contractility, diastolic dysfunction and enlarged left atria in bothHCM
models; the phenotype was more pronounced in the R92Q mice. In E163R ven-
tricular myofibrils, in spite of a significant increase in the rate of the initial iso-
metric slow phase of relaxation, overall relaxation frommaximal activation was
impaired and prolongedvsWTandR92Qmyofibrils that exhibited similar relax-
ation kinetics. Resting tension was higher in the E163Q compared to WT and
R92Qmyofibrils. Isometric ATPase both at rest and at maximal Ca2þ-activation
and the energy cost of tension generation were increased in E163R vs WT and
R92Q skinned trabeculae. Myofilament Ca2þ-sensitivity was increased in both
mutant lines compared to WT; the change was larger in the R92Q preparations.
R92Q intact cardiomyocytes and trabeculae compared to WT and E163R prep-
arations showed blunted response to inotropic interventions, reduced amplitude
and slower decay of Ca2þ-transients with reduced SERCA function. Twitch ki-
netics were prolonged in both HCM mouse models, despite Ca2þ-transient ki-
netics was faster and SERCA function unchanged in the E163R mice. Intact
preparations of both HCM mouse models showed increased probability of ar-
rhythmogenic behavior that increased in response to isoproterenol. The results
suggest that similar HCM phenotypes can be generated through different patho-
genic pathways. Grant Telethon-GGP13162.1469-Pos Board B420
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The effect of the TnI R21C mutation in the human cardiac troponin I, the mu-
tation that is linked to hypertrophic cardiomyopathy, on muscles of the left
(LV) and right (RV) ventricles was examined in the knock-in mice. Experi-
ments were on a mesoscopic scale where the contribution of a single molecule
makes difference to the overall signal. We examined 3-4 actin molecules in
ex-vivo myofibrils prepared from LV and RV muscles. Experiments revealed
that the mutation imposed significant differences in the distribution of actin
angles: during contraction, actin from LV were much more tightly distributed
compared to actin from RV. They also revealed that the mutation imposed
significant difference on the kinetics cycle of cross-bridges (XBs) of the
LV and RV: XBs from RV displayed a 3-fold decrease in the rate of power
stroke and a 2-fold decrease in the rate of dissociation from thin filaments
as compared to LV. We speculate that mutation operates differently in both
ventricles because of the differences in external load between LV and RV.
Kinetic results suggest that an increase in isometric tension observed in
mutated RV results from an inability of XBs to dissociate promptly from
thin filaments.
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The contraction of the right ventricle (RV) expels blood into the pulmonary cir-
culation, and the contraction of the left ventricle (LV) pumps blood into the sys-
temic circulation through the aorta. The respective afterloads imposed on the
LV and RV by aortic and pulmonary artery pressures create very different me-
chanical requirements for the two ventricles. Indeed, differences have been
observed in the contractile performance between left and right ventricular my-
ocytes in muscle growth, in dilated cardiomyopathy, in congestive heart failure,
and in energy usage and speed of contraction at light loads in healthy hearts. In
spite of these functional differences, it is commonly believed that the right and
left ventricular muscles are identical because there were no differences in stress
development, twitch duration, work performance and power among the RV and
LV in dogs. This report shows that on a mesoscopic scale (when only a few
molecules are studied (here 3-6 molecules of actin in ex-vivo ventricular myo-
fibrils), the two ventricles in rigor differ in the degree of orientational disorder
of actin within thin filaments, and during contraction they differ in the kinetics
of the cross-bridge cycle.
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Compared to non-failing RV, we reported that in failing RV the inotropic
response to stimulation of a1-adrenergic receptors (a1-ARs) was increased.
Recently we found that a single a1-AR subtype (a1A) was responsible. How-
ever, the significance of increased a1A responses remains unclear.
Goal: Determine if increased a1A-mediated inotropy is beneficial in RV failure
and if the a1A-subtype is a potential therapeutic target.
Methods: We used a RV-specific failure model in mice. Tracheal instillation of
the fibrogenic antibiotic bleomycin induced pulmonary fibrosis, pulmonary hy-
pertension, and RV failure within 2-3 wk. We assessed survival and investi-
gated the cellular mechanisms contributing to increased a1A inotropy in
failing RV. Furthermore, in the context of bleomycin induced RV failure, we
determined if there was a beneficial effect of chronic (2 wk.) treatment of
mice with the a1A agonist A61603 using osmotic mini-pump infusion.
Results: For non-failing RV, acute a1A stimulation with A61603 induced a
negative inotropic effect. In contrast, for failing RV, acute a1A stimulation
